A detailed history of Deep Currents Investment Group LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Deep Currents Investment Group LLC holds 750 shares of BMRN stock, worth $49,155. This represents 0.11% of its overall portfolio holdings.

Number of Shares
750
Previous 117,182 99.36%
Holding current value
$49,155
Previous $9.65 Million 99.46%
% of portfolio
0.11%
Previous 15.8%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$69.02 - $93.84 $3.14 Million - $4.26 Million
-45,447 Reduced 38.78%
71,735 $5.04 Million
Q2 2024

Aug 14, 2024

SELL
$74.43 - $92.22 $1.35 Million - $1.68 Million
-18,166 Reduced 13.42%
117,182 $9.65 Million
Q1 2024

May 15, 2024

SELL
$83.81 - $99.0 $1.49 Million - $1.77 Million
-17,836 Reduced 11.64%
135,348 $11.8 Million
Q4 2023

Feb 14, 2024

BUY
$76.22 - $98.51 $384,682 - $497,179
5,047 Added 3.41%
153,184 $14.8 Million
Q3 2023

Nov 14, 2023

BUY
$85.07 - $94.48 $368,268 - $409,003
4,329 Added 3.01%
148,137 $13.1 Million
Q2 2023

Aug 14, 2023

SELL
$86.68 - $100.3 $4.33 Million - $5.01 Million
-49,925 Reduced 25.77%
143,808 $12.5 Million
Q1 2023

May 15, 2023

BUY
$87.74 - $117.27 $552,498 - $738,449
6,297 Added 3.36%
193,733 $18.8 Million
Q4 2022

Feb 14, 2023

BUY
$80.93 - $108.63 $975,449 - $1.31 Million
12,053 Added 6.87%
187,436 $19.4 Million
Q3 2022

Nov 14, 2022

BUY
$82.16 - $96.94 $1.34 Million - $1.58 Million
16,312 Added 10.25%
175,383 $14.9 Million
Q2 2022

Aug 15, 2022

BUY
$71.48 - $86.85 $2.02 Million - $2.45 Million
28,216 Added 21.56%
159,071 $13.2 Million
Q1 2022

May 16, 2022

BUY
$74.28 - $92.69 $5.01 Million - $6.25 Million
67,395 Added 106.2%
130,855 $10.1 Million
Q1 2020

May 15, 2020

SELL
$71.37 - $96.85 $857,653 - $1.16 Million
-12,017 Reduced 15.92%
63,460 $5.36 Million
Q4 2019

Feb 14, 2020

BUY
$64.27 - $86.37 $2.76 Million - $3.71 Million
42,986 Added 132.3%
75,477 $6.38 Million
Q3 2019

Nov 14, 2019

SELL
$67.4 - $85.11 $951,014 - $1.2 Million
-14,110 Reduced 30.28%
32,491 $2.19 Million
Q2 2019

Aug 14, 2019

SELL
$80.35 - $93.9 $1.42 Million - $1.65 Million
-17,617 Reduced 27.43%
46,601 $3.99 Million
Q1 2019

May 15, 2019

SELL
$84.2 - $98.62 $6.79 Million - $7.95 Million
-80,591 Reduced 55.65%
64,218 $5.7 Million
Q4 2018

Feb 14, 2019

BUY
$80.14 - $106.07 $11.6 Million - $15.4 Million
144,809 New
144,809 $12.3 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.2B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Deep Currents Investment Group LLC Portfolio

Follow Deep Currents Investment Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deep Currents Investment Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Deep Currents Investment Group LLC with notifications on news.